NASDAQ · GROW

US Global Investors Inc.

$2.92 -$0.01 (-0.34%) 1D Market open

Key Metrics

$36.34M
Market cap
10.41×
P/E · TTM
Revenue · TTM
$3.49M
Net income
EPS · TTM $0.27
Dividend yield
Free cash flow
Beta · 1Y 0.68
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Apr 16
    The stock moved +11.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 16
  • Apr 8
    From its Mar 10 high, the share price fell 28%.

    Peak close $3.37 on Mar 10; trough close $2.43 on Apr 8. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -28%
  • Mar 27
    The stock moved -10.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 27

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$36.34M
Enterprise value
Shares outstanding12.4M
52-wk range$2.23 – $3.65
Avg volume · 20D76.5K
Net cash
Book value / share$3.60
IndustryInvestment Advice
ExchangeNASDAQ
About US Global Investors Inc.
IPO dateApr 24, 1985
Employees24

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E10.41
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №$4.71

Profitability

Gross
Operating
Net
FCF
ROE / ROIC 7.3% · —

Financial Health

Current ratio20.91
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$36.23M

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

$4.71 vs $2.97
Trades below classic defensive value — Graham-cheap
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings